Platform Therapeutics, Inc.

New Filing

CIK: 0002152141·Biotechnology·DELAWARE·Filed: Aug 27, 2026

Total Offering

$4,000,000

Amount Sold

$1,750,000

Investors

1

First Sale

Aug 12, 2026

Offering Details

Type: Equity
Exemptions: Rule 506(b)
Entity Type: Corporation
Year Incorporated: 2022
Non-Accredited Investors: No

Related Persons

Name	Role
JAMES WILKIE
LAKHMIR CHAWLA

Company

Platform Therapeutics, Inc.

300 BRICKSTONE SQUARE, STE 201

ANDOVER, MA, 01810

339-224-0265

SEC Filing

0002152141-26-000001

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.